%0 Generic
%T Multicentre phase II study of imatinib mesylate in patients with recurrent glioblastoma: An EORTC: NDDG/BTG Intergroup Study
%A Raymond, E.
%A Brandes, A.
%A Van Oosterom, A.
%A Dittrich, C.
%A Fumoleau, P.
%A Coudert, B.
%A Twelves, C.
%A De Balincourt, C.
%A Lacombe, D.
%A Van Den Bent, M.
%I American Society of Clinical Oncology (ASCO)
%@ 0732-183X
%@ 1527-7755
%K Cancer Research
%K Oncology
%D 2004
%C American Society of Clinical Oncology (ASCO)
%U http://slubdd.de/katalog?TN_libero_mab2
Download citation